The PPARγ Agonist Pioglitazone Is Effective in the MPTP Mouse Model of Parkinson's Disease Through Inhibition of Monoamine Oxidase B

British Journal of Pharmacology - United States
doi 10.1038/bjp.2008.78
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Monoamine Oxidase Inhibition

Biochemical Society Transactions
Biochemistry
1994English

Pioglitazone Reduces Β Amyloid Levels via Inhibition of PPARγ Phosphorylation in a Neuronal Model of Alzheimer’s Disease

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2019English

Selegiline Rescues Gait Deficits and the Loss of Dopaminergic Neurons in a Subacute MPTP Mouse Model of Parkinson's Disease

International Journal of Molecular Medicine
MedicineGenetics
2013English

Controversies in Neurology: Why Monoamine Oxidase B Inhibitors Could Be a Good Choice for the Initial Treatment of Parkinson's Disease

BMC Neurology
MedicineNeurology
2011English

Potentiation of Ligand Binding Through Cooperative Effects in Monoamine Oxidase B

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2010English

Effect of Tomato Intake on Striatal Monoamine Level in a Mouse Model of Experimental Parkinson's Disease.

Journal of Nutritional Science and Vitaminology
MedicineNutritionDietetics
2002English

Monoamine Oxidase and Its Inhibition.

Annals of Internal Medicine
Internal MedicineMedicine
1977English

Loss of Enteric Dopaminergic Neurons and Associated Changes in Colon Motility in an MPTP Mouse Model of Parkinson's Disease

Experimental Neurology
Developmental NeuroscienceNeurology
2007English

Reassessment of Subacute MPTP-treated Mice as Animal Model of Parkinson's Disease

Acta Pharmacologica Sinica
MedicinePharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy